CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $383,000 | -52.8% | 51,891 | -28.2% | 0.02% | -58.7% |
| Q2 2019 | $811,000 | +126.5% | 72,291 | +360.6% | 0.05% | +206.7% |
| Q2 2018 | $358,000 | -39.3% | 15,694 | -24.4% | 0.02% | -37.5% |
| Q1 2018 | $590,000 | -40.5% | 20,751 | -55.8% | 0.02% | -45.5% |
| Q4 2017 | $991,000 | +290.2% | 46,980 | +235.3% | 0.04% | +238.5% |
| Q3 2017 | $254,000 | +41.9% | 14,012 | +34.7% | 0.01% | +62.5% |
| Q1 2017 | $179,000 | – | 10,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |